Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Viral Hepatitis

Quick Links

Veterans Crisis Line Badge
My healthevet badge

Management strategy of HCC based on CTP class, size, and performance status

for Health Care Providers

Table 12. Management strategy of HCC based on CTP class, size, and performance status

Back to Cirrhosis Recommendations

CTP, Child-Turcotte-Pugh; HCC, hepatocellular carcinoma, HVPG; hepatic venous pressure gradient; PEI, percutaneous ethanol injection; PS, performance status; RFA, radiofrequency ablation.
CTP A, PS 0Single HCC <2 cmHVPG <10 mm Hg and bilirubin <1.5 mg/dl
  • Surgical resection
Varices/collaterals or HVPG >10 mm Hg or bilirubin >1.5 mg/dl
  • Liver transplant evaluation
  • RFA/PEI
CTP A-B, PS 0-2Single HCC 2-5 cmHVPG <10 mm Hg and bilirubin <1.5 mg/dl
  • Surgical resection
Varices/collaterals or HVPG >10 mm Hg or bilirubin >1.5 mg/dl
  • Liver transplant evaluation
  • RFA/PEI
2 or 3 HCC masses <3 cm (the largest)
  • Liver transplant evaluation
  • Radiofrequency ablation
Intermediate stage (multinodular , PS 0)Transarterial chemoembolization
Advanced stage (portal invasion, metastases)Sorafenib
CTP C, PS >2Terminal stageSymptomatic treatment

From Management and Treatment of Patients with Cirrhosis and Portal Hypertension